Comments on: Ambit Biosciences, In Third Incarnation, Gears Up for Pivotal Study of Leukemia Drug http://www.xconomy.com/san-diego/2009/09/10/ambit-biosciences-in-third-incarnation-gears-up-for-pivotal-study-of-leukemia-drug/ Business + Technology in the Exponential Economy Sat, 11 Feb 2012 09:14:03 +0000 hourly 1 http://wordpress.org/?v=3.0.4 By: Dr. Ashok Srivastava, DM, Ph.D., MBA, Medical Oncology, CMO and EVP http://www.xconomy.com/san-diego/2009/09/10/ambit-biosciences-in-third-incarnation-gears-up-for-pivotal-study-of-leukemia-drug/comment-page-1/#comment-86743 Dr. Ashok Srivastava, DM, Ph.D., MBA, Medical Oncology, CMO and EVP Tue, 13 Oct 2009 22:39:52 +0000 http://www.xconomy.com/?p=40816#comment-86743 It is great news in the drug development and I congratulate to the Ambiant Biosciences for great success, I will be happy to provide a globa CRO support to this product globally. Please contact me, Dr. Ashok Srivastava, DM, Ph.D., MBA CMO and EVP Cell. 908-720-9315 Office: 732-694-3394 It is great news in the drug development and I congratulate to the Ambiant Biosciences for great success,
I will be happy to provide a globa CRO support to this product globally.

Please contact me,

Dr. Ashok Srivastava, DM, Ph.D., MBA
CMO and EVP
Cell. 908-720-9315
Office: 732-694-3394

]]>